NASDAQ: IMRN
Immuron Ltd Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their IMRN stock forecasts and price targets.

Forecast return on equity

Is IMRN forecast to generate an efficient return?

Company
-35.06%
Industry
87.26%
Market
66.99%
IMRN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IMRN forecast to generate an efficient return on assets?

Company
-29.79%
Industry
23.95%
IMRN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IMRN revenue growth forecast

How is IMRN forecast to perform vs Biotechnology companies and vs the US market?

Company
51.71%
Industry
126.09%
Market
10.36%
IMRN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IMRN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IMRN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IMRN$1.78N/AN/A
CBIO$15.89$25.00+57.33%Strong Buy
PSTV$0.30$10.83+3,511.00%Buy
APRE$1.74$20.00+1,049.43%Buy
PTHS$16.19N/AN/A

Immuron Stock Forecast FAQ

What is IMRN's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: IMRN) forecast ROE is -35.06%, which is considered weak.

If you're new to stock investing, here's how to buy Immuron stock.

What is IMRN's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: IMRN) forecast ROA is -29.79%, which is lower than the forecast US Biotechnology industry average of 23.95%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.